Document is current

Article History

Received: 3 September 2025

Accepted: 21 February 2026

First Online: 4 March 2026

Declarations

:

: The author is the Executive Director of the Female Orgasm Research Institute, a 501(c)(3) nonprofit organization dedicated to advancing scientific research on female orgasm function and evidence-based pathways to orgasm, and the Founder of the Women’s Cannabis Project, its advocacy arm, which petitions U.S. states to add Female Orgasmic Disorder/Difficulty (FOD) as a qualifying condition for medical cannabis. She is also the Executive Director/Instructor of the Female Orgasm Training Institute and is developing professional training programs on the use of cannabis in the treatment of FOD. The author has received no financial support from any industry for this work, and there are no other competing interests to declare.

: Financial Interests : The author is the Founder of the Female Orgasm Training Institute, which is developing professional training programs on the use of cannabis in the treatment of Female Orgasmic Disorder/Difficulty (FOD).

: The author is the Executive Director of the Female Orgasm Research Institute, a 501(c)(3) nonprofit organization dedicated to advancing scientific research on female orgasmic function and evidence-based pathways to orgasm. She is also the Founder of the Women’s Cannabis Project, the Institute’s advocacy arm, which petitions U.S. states to add FOD as a qualifying condition for medical cannabis.

: All reported studies involving human participants performed by the authors were conducted in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the studies. No animal studies were performed by the authors for this article.